首页> 外文期刊>Blood cancer journal. >Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma
【24h】

Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma

机译:胚胎干细胞转录因子Sox2在ALK阳性间变性大细胞淋巴瘤中的异常表达及其生物学意义

获取原文
获取外文期刊封面目录资料

摘要

Sox2 (sex-determining region Y-Box) is one of the master transcriptional factors that are important in maintaining the pluripotency of embryonic stem cells (ESCs). In line with this function, Sox2 expression is largely restricted to ESCs and somatic stem cells. We report that Sox2 is expressed in cell lines and tumor samples derived from ALK-positive anaplastic large cell lymphoma (ALK+ALCL), for which the normal cellular counterpart is believed to be mature T-cells. The expression of Sox2 in ALK+ALCL can be attributed to nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), the oncogenic fusion protein carrying a central pathogenetic role in these tumors. By confocal microscopy, Sox2 protein was detectable in virtually all cells in ALK+ALCL cell lines. However, the transcriptional activity of Sox2, as assessed using a Sox2-responsive reporter construct, was detectable only in a small proportion of cells. Importantly, downregulation of Sox2 using short interfering RNA in isolated Sox2active cells, but not Sox2inactive cells, resulted in a significant decrease in cell growth, invasiveness and tumorigenicity. To conclude, ALK+ALCL represents the first example of a hematologic malignancy that aberrantly expresses Sox2, which represents a novel mechanism by which NPM-ALK mediates tumorigenesis. We also found that the transcriptional activity and oncogenic effects of Sox2 can be heterogeneous in cancer cells.. ? 2012 Macmillan Publishers Limited
机译:Sox2(决定性别的区域Y-Box)是主要的转录因子之一,对维持胚胎干细胞(ESCs)的多能性很重要。与该功能一致,Sox2表达在很大程度上限于ESC和体干细胞。我们报告说,Sox2在源自ALK阳性间变性大细胞淋巴瘤(ALK + ALCL)的细胞系和肿瘤样品中表达,据信正常细胞对应物是成熟的T细胞。 Sox2在ALK + ALCL中的表达可归因于核致磷脂-间变性淋巴瘤激酶(NPM-ALK),这是一种致癌融合蛋白,在这些肿瘤中具有重要的致病作用。通过共聚焦显微镜,在ALK + ALCL细胞系中几乎所有细胞中都可以检测到Sox2蛋白。但是,使用Sox2反应性报告基因构建物评估的Sox2转录活性只能在小部分细胞中检测到。重要的是,在分离的Sox2 活性细胞中使用短干扰RNA来下调Sox2,而不是在Sox2 inactive 细胞中不引起细胞生长,侵袭性和致瘤性的显着降低。总之,ALK + ALCL代表了异常表达Sox2的血液系统恶性肿瘤的第一个例子,这代表了NPM-ALK介导肿瘤发生的新机制。我们还发现Sox2的转录活性和致癌作用在癌细胞中可能是异质的。 2012 Macmillan Publishers Limited

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号